Inspire Medical Systems price to book ratio INSP
Market value divided by the book value of the company's net assets, since 2018.
- Today, Oct 23, 2026
- 2.5×
- 8-year median
- 11.0×
- Against its 8-year history
- 8th
- percentile: 0 is its lowest day, 100 its highest
- 8-year range
- 1.5× to 34.7×
- Peer median
- 4.8×
Inspire Medical Systems' price to book ratio is 2.5× as of Oct 23, 2026.
That is below its 8-year median of 11.0×, lower than on 92% of days in the last 8 years.
Over that time it ranged from 1.5× in May 2026 to 34.7× in Nov 2021.
The median for 10 medical instruments and supplies stocks of a similar size is 4.8×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 2.5× | 1.5× | 4.3× |
| 2025 | 4.2× | 3.1× | 8.7× |
| 2024 | 8.1× | 6.3× | 12.9× |
| 2023 | 11.0× | 6.8× | 18.8× |
| 2022 | 15.5× | 12.7× | 32.0× |
| 2021 | 28.6× | 20.1× | 34.7× |
| 2020 | 22.1× | 7.9× | 23.6× |
| 2019 | 12.2× | 6.7× | 12.5× |
| 2018 | 9.1× | 8.1× | 11.4× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Inspire Medical Systems' size, closest first, today.
| Company | Price to book ratio |
|---|---|
| INSPInspire Medical Systems | 2.5× |
| LMATLemaitre Vascular | 4.6× |
| UFPTUFP Technologies | 5.0× |
| EYENational Vision | 1.6× |
| ATRCAtriCure | 5.8× |
| WRBYWarby Parker | 8.2× |
| CDRECadre | 3.7× |
| BVSBioventus | 5.5× |
| STAAStaar Surgical | 3.1× |
| NVSTEnvista | 1.2× |
| IRMDIradimed | 10.8× |
| Peer median | 4.8× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Inspire Medical Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.